These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3327648)

  • 21. Micronized progesterone: a new therapeutic option.
    Langer RD
    Int J Fertil Womens Med; 1999; 44(2):67-73. PubMed ID: 10338263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the oral administration of micronized progesterone on plasma and tissue levels of steroids in human pregnancy.
    Ferre F; Uzan M; Jolivet A; Janssens Y; Tanguy G; Sureau C; Cedard L
    Acta Physiol Hung; 1985; 65(4):443-51. PubMed ID: 4013776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Borraccino V; Petruzzi D; Mazzotta N; Cerundolo ML; Schönauer LM
    Fertil Steril; 1996 Apr; 65(4):860-2. PubMed ID: 8654651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modern therapy with micronized of progesterone--utrogestan for menstrual disturbances].
    Sirakov M
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():22-4. PubMed ID: 11785350
    [No Abstract]   [Full Text] [Related]  

  • 26. Progesterone: review of safety for clinical studies.
    Goletiani NV; Keith DR; Gorsky SJ
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):427-44. PubMed ID: 17924777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
    Gompel A
    Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of oral micronized progesterone.
    Maxson WS; Hargrove JT
    Fertil Steril; 1985 Nov; 44(5):622-6. PubMed ID: 4054341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A; Hahn DW; McGuire JL
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
    Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
    Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of micronized natural progesterone on the liver during the third trimester of pregnancy].
    Benifla JL; Dumont M; Levardon M; Foucher E; Cadiot G; Crenn-Hebert C; Heid M; Lelaidier C; Rosenbaum A; Bernuau J; Erlinger S; Frydman R; Madelenat P
    Contracept Fertil Sex; 1997 Feb; 25(2):165-9. PubMed ID: 9116778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
    Simon JA
    Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of oral micronized progesterone when applied via vaginal route.
    Choavaratana R; Manoch D
    J Med Assoc Thai; 2004 May; 87(5):455-8. PubMed ID: 15222511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of micronized progesterone in the treatment of menace of preterm delivery.
    Noblot G; Audra P; Dargent D; Faguer B; Mellier G
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(3):203-9. PubMed ID: 1879595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of short-term micronized progesterone on bone turnover in postmenopausal women.
    Ikram Z; Dulipsingh L; Prestwood KM
    J Womens Health Gend Based Med; 1999 Sep; 8(7):973-8. PubMed ID: 10534300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor.
    Arikan I; Barut A; Harma M; Harma IM
    Gynecol Obstet Invest; 2011; 72(4):269-73. PubMed ID: 22086108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone.
    Mueck AO
    Climacteric; 2012 Apr; 15 Suppl 1():11-7. PubMed ID: 22432811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey.
    Fitzpatrick LA; Pace C; Wiita B
    J Womens Health Gend Based Med; 2000 May; 9(4):381-7. PubMed ID: 10868610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.